Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aromatase Inhibitor Effects on Ovarian Function During the Follicular and Early Luteal Phase in Women
NCT01046578Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Jan 2010
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of letrozole in contraception (7 arms), sponsored by University of Saskatchewan. Primary endpoint: Fate of the dominant follicle or luteal structure. Started Jan 2010; status: completed.
02
Drugs
letrozole
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01046578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046578.